Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-03-01
2005-03-01
Desai, Rita (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
06861445
ABSTRACT:
The invention relates to compounds of Formula (I), to processes for their preparation and pharmaceutical compositions thereof, that inhibit the Ras farnesyl-protein transferase enzyme (FPTase), and may be used as an alternative to, or in conjunction with, traditional cancer therapy for the treatment of ras oncogene-dependent tumors, such as cancers of the pancreas, colon, bladder, and thyroid
REFERENCES:
patent: WO 9524400 (1995-09-01), None
patent: WO 9736605 (1997-10-01), None
patent: WO 9807692 (1998-02-01), None
patent: WO 9905117 (1999-02-01), None
patent: WO 0185685 (2001-11-01), None
J.L. Bos, Cancer Res., 1989, 49, 4682.
P.J. Casey, P.A. Solski, C.J. Der, J.E. Buss, Proc. Natl. Acad. Sci. U.S.A., 1989, 86, 8323.
J.F. Hancock, H. Paterson, C.J. Marshall, Cell, 1990, 63, 133.
Zask, et al., J. Med. Chem., 1990, 33, 1418-1423.
P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMohan, D. Vistica, J. Warren, J. Bokesh, S. Kenney, M.R. Boyd, J. Natl. Cancer Instit., 1990, 82(13), 1107-1112.
L.V. Rubinstein, R.H. Shoemaker, K.D. Paull, R.M. Simon, S. Tosini, P. Skehan, D.A. Scudiero, A. Monks, M.R. Boyd, J. Natl. Cancer Instit., 1990, 82(13), 1113-1118.
J.F. Moomaw, P.J. Casey, J. Biol. Chem., 1992, 267, 17438-17443.
M.A. Garcia, et al.,J. Biol. Chem., 1993, 268, 18415-18420.
G.L. Bolton, J.S. Sebolt-Leopold, J.C. Hodges; Annu. Rep. Med. Chem., 1994, 29, 165.
R.J.A. Grand in “New Molecular Targets in Cancer Chemotherapy”, J.D. Kerr and P. Workman, Eds. CRC Press, Boca Raton, FL., 1994, p. 97.
G.L. James, M.S. Brown, J.L. Goldstein, Methods in Enzymology, 1995, 255, 38-46.
M.R. Boyd, K.D. Paull, Drug Development Res., 1995, 34, 91-109.
S.P. Fricker, R.G. Buckley, Anticancer Research, 1996, 16, 3755-3760.
S. Ayral-Kaloustian, J.S. Skotnicki, Annu. Rep. Med. Chem., 1996, 31, 171.
T.M. Williams, Exp. Opin. Ther. Patents, 1998, 8, 553.
SCH-66336, Pharmaprojects, 1998, No. 5128.
R-115777, Pharmaprojects, 1998, No. 5532.
Ayral-Kaloustian Semiramis
Epstein Joseph William
Moran Daniel B.
Shiao Robert
Wyeth Holdings Corporation
LandOfFree
3-Substituted-3-(substitutedsulfonyl or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-Substituted-3-(substitutedsulfonyl or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-Substituted-3-(substitutedsulfonyl or... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3376272